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Summary.-Four sub-fractions of carcinoembryonic antigen have been obtained
by chromatography of conventional CEA on Con A-Sepharose and their immuno-
reactive contents have been determined. Comparative studies have shown that
a fraction eluted with 2% methyl glucoside (CEA 2B) had the highest activity, with
a potency (60 u/,ug) twice that of unfractionated CEA although appreciable activity
was also found in the other fractions. The amino acid composition of CEA 2B is
similar to that reported for conventional CEA but there is a lower content of neutral
hexoses and a comparatively high content of N-acetylglucosamine. Experiments
with a pool of sera from 11 patients with colonic cancer, which had been fractionated
on Con A-Sepharose, have shown that nearly all the CEA activity was contained
in a fraction eluted with 2% methyl glucoside. A convenient method of isolating
CEA with high specific activity directly from perchloric acid extracts of tumour
tissue is also described.
CARCINOEMBRYONIC antigen (CEA),
first isolated by Gold and Freedman
(1965) is an immunoreactive macro-
molecular glycoprotein found on the sur-
face of human colonic tumour cells. It
can be detected in relatively high amounts
in the sera of patients with metastatic
colonic cancer although it is present in
moderate to low amounts in the sera
of patients with primary lesions of
various cancers and with various non-
malignant diseases (LoGerfo, Krupey and
Hansen, 1971). The conventional method
of isolating CEA involves perchloric acid
extraction of colonic metastases followed
by large scale exclusion chromatography
on Sepharose 4B and Sephadex G-200
(Coligan et al., 1972). Our recent studies
(Rogers, Searle and Bagshawe, 1974;
Rogers, Searle and Wass, 1975) have
shown that CEA isolated in this way,
and also its desialylated product, can
be fractionated into 3 immunologically
active sub-fractions using Concanavalin A
affinity chromatography. Independent
24
studies, which confirm some of our earlier
results have since been reported (Boenisch
and N0rgaard-Pederson, 1975; Harvey
and Chu, 1975). Here we report on the
further fractionation of CEA on Con
A-Sepharose using sodium borate buffer
and on the immunoreactive content of
these fractions. The use of Con A
affinity chromatography as a simple and
effective way of isolating CEA with
high specific activity is also described.
MATERIALS AND AIETHODS
Unfractionated CEA was prepared from
several metastatic colonic tumours using
the method of Coligan et al., 1972. The
yield of our assay standard (M-12) prepared
by this method was 30 mg protein/kg wet
tissue. Unfractionated CEA w%as separated
into 3 fractions on a column of Concanavalin
A-Sepharose (Pharmacia) as previously de-
scribed (Rogers et al., 1974). Briefly, this
involved elution of fraction 1 with 01 M
sodium acetate buffer pH 6 containing 1 M
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10-3 M MnCl2. Fractions 2 and 3 were then
respectively eluted with 2%o and 10o
methyl glucoside solutions in the above
buffer.
Further fractionation of fraction 2. CEA
fraction 2 (5 mg, measured as protein) after
dialysis against the acetate buffer was con-
centrated to 2 ml using an Amicon PM 10
membrane and re-chromatographed on a
fresh column of Con A-Sepharose which
was eluted with 01 M sodium borate/phos-
phate buffer pH 6 to obtain fraction 2A
and subsequently with 2% methyl glucoside
solution in the acetate buffer to obtain
fraction 2B. Starting with unfractionated
CEA it was possible to obtain four fractions
(1, 2A, 2B and 3) by successively eluting the
column with the acetate buffer, the borate
buffer, 2% methyl glucoside and 10% methyl
glucoside.
Radioimmunoassay of CEA.-CEA acti-
vity of the fractions after dialysis against
distilled water was determined by the double
antibody assay using preparation M-12 as
both standard and label, and "' ace " 36
antiserum (Searle et al., 1974). The relative
potencies of unfractionated CEA, fraction
2B and the MRC reference preparation
73/601 were determined by calculating the
percentage of inhibition of 1251-CEA in
the presence of the unlabelled CEA. Glyco-
protein concentration was expressed as
freeze-dried weight obtained after drying
over P205 except in the case of the MRC
preparation where 10 Htg of freeze-dried CEA
powder is contained in 0 5 ml ofreconstituted
solution.
Large scale isolation of CEA using Con A
qJinity chromatography.-Liver metastases
of colonic tumours (500 g) were homogenized
in water and extracted with perchloric acid
as previously described (Coligan et al., 1972).
The extract, after extensive dialysis against
tap water, was concentrated using an Amicon
PM 10 membrane (10 ml for each 500 g of
tumour). An equal volume of the acetate
buffer was then added and the solution
passed through a 0-22 ,um Millipore filter.
The filtrate wvas applied to a column of
Con A-Sepharose (96 ml) and eluted sequen-
tially with the acetate buffer, the borate
buffer, 2% methyl glucoside and 10% methyl
glucoside. The fractions wA-ere monitored
for CEA activity by Ouchterlony diffusion
reactions using monospecific anti-CEA anti-
serum raised to unfractionated CEA, and
by inhibition of '251-labelled standard CEA-
antibody reactions as employed in our routine
double-antibody assay. High activity CEA
was eluted with 2%o methyl glucoside and
concentrated to 2 ml. It was further purified
on a calibrated column of Biogel P-200
(200 ml) which was equilibriated with 0-1 M
phosphate buffered saline pH 4-5. The
CEA was eluted as the first of two peaks
soon after the void volume indicating a
mol. wt. of 180,000. The sample was
freeze-dried and assayed for CEA activity
(Table I). The total yield was 2-8 mg.
RESULTS AND DISCUSSION
The recovery of CEA protein in each
fraction from the Con A affinity chromato-
graphy varied with different preparations.
However, typical recoveries for fractions
1, 2A, 2B and 3 were 10, 10, 40 and
20% respectively. CEA fractions 2A and
2B produced a line of identity on double
diffusion with anti-CEA antiserum al-
though the line given by fraction 2B
was always somewhat sharper. On a
weight to weight basis fraction 2B had
the highest immunological activity by
direct measurement in our routine CEA
assay although the activities detected
in the other fractions were appreciable
(Table I). The activity of fraction 2B
has been confirmed by comparative in-
hibition assays demonstrating the ability
of fraction 2B and our assay standard
TABLE I.-Activity and Carbohydrate Con-
tent of CEA Fractions
Fraction
Unfractionated
1
2
2A
2B
3
Large scale
isolation
Activity
(%o)*
100
23
170
66
196
110
174
Neutral Carbohydrate
hexoset (%)t
56
1-18 70
0 39 42
0-66 42
0-31 38
0-51 44
39
* CEA activity expressed as % activity on a
weight to weight basis of assay standard CEA
(M-12).
t Neutral sugar including fucose was estimated
by the orcinol sulphuric acid method and expressed
as mg/mg Lowry protein.
I Total carbohydrate deduced from the freeze-
dried weight after subtracting Lowry protein.
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(M-12), measured as freeze-dried weights,
and the MRC reference CEA (where
10 ,Ig of CEA powder is contained in
0 5 ml of reconstituted solution) to inhibit
the binding of unfractionated 1251-CEA
by anti-CEA antiserum (Todd " ace "
36). Parallel inhibition curves are shown
(Fig. 1) for the three activities. The
potencies of preparations M-12 and frac-
tion 2B were 30 and 60 units of CEA/,ag
offreeze-dried powder respectively. These
preparations are therefore approximately
3 x and 6 x the potency of the MRC
reference preparation where approxim-
ately 1 0,ag of freeze-dried CEA contains
10 units ofactivity (Laurence et al., 1975).
The above results show that the potency
of conventional CEA preparations may
vary considerably and also that it can
be improved 2 x by Concanavalin A
affinity chromatography using the appro-
priate buffer systems.
The amino acid content (Table II)
of fraction 2B is very similar to that
80
70
6Q
50
z
0
Go
I
z
0ll
40
30
20
1 0
TABLE II.-Amino Acid Composition
of CEA 2B
Mol amino acid/105 g protein
Asp 144 6
Thr 79 5
Ser 90 4
Glu 113-1
Pro 82-3
Gly 56 9
Ala 60 7
A Cys trace
Val 66 0
Met 4.7
Ile 37 5
Leu 84 7
Tyr 3:3 3
Phe 33 8
His 14 3
Lys 43 -
Arg 31-9
Amino acids were (determined by the method
of Liu and Chang (1971) on a sample hydrolysed
for 24 h at 100°C in 3 M p-toluenesulphonic acid.
(Uncorrected figures.)
reported for
tions (Terry
the protein
there is no
conventional CEA prepara-
et al., 1974) indicating that
may be very similar, but
conclusive evidence ruling
0
10 1000 100
ng CEA (Freeze-Dried Wt )
FIG. 1. Comparative inhibition curves of CEA, M-12 (v), Fraction 2B (0) and the MRC reference
CEA (0) demonstrating the inhibition of binding of 1251-CEA (M-12) to goat anti-CEA " ace "
36.
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,IM/100 mg m
(Iry wxeight pr
44.9
42 6
56 4
109 7
not detecte(l
trace
* Neutral sugars were cleterminedl by gas liqui(d
chromatography (g.l.c.) according to the method of
Clamp, Bhatti and Chambers (1972) using mannitol
as internal standard. Amino sugars wNere estimatedt
by the method of Allen and Neuberger (1975) on
an amino acid analyser after hydrolysis in p-toluene-
sulphonic acid.
t The carbohydrate was calculated fromn the
total recovery of monosaccharides per mg of Lowry
protein.
out heterogeneity in the protein structure
of CEA. It is shown (Table I) that
fraction 2B has a lower content of neutral
hexose than fraction 2A or the others.
However it is comparatively rich in
N-acetylglucosamine (Table III) suggest-
ing that some of the exterior hexose
residues may be missing in this fraction
of CEA. Since the total carbohydrate
content of fraction 2B is significantly
less than the values reported for con-
ventional CEA (Terry et al., 1974) our
results may help to explain the wide
variation in both hexose composition and
total carbohydrate content reported for
various CEA preparations. The figures
usually obtained are necessarily composite
values dependent on the proportions of
the CEA fractions which we have shown
to vary with different preparations. There
is good agreement between the carbo-
hydrate content of fraction 2B deduced
from the carbohvdrate and protein ana-
lyses (Table III) and that obtained from
the freeze-dried weight indicating that
tightly bound water in the freeze-dried
powder is negligible (cf. Terry et al.,
1974).
The mol. wt. of fraction 2B is 180,000
estimated by gel filtration. This value
is estimated to be subject to an error
of +30,000 and is at the lower end of
the range of mol. wt. values (200-300,000)
obtained for CEA from various sources
(Coligan et al., 1972; Pusztaszeri and
Mach, 1973). Variation in the mol. wt.
of CEA preparations may also be a direct
result of the varying carbohydrate con-
tent of individual preparations. In view
of this, a mol. wt. of 180,000 for fraction
2B would appear to be compatibie
with our estimate of the carbohydrate
content.
Our fractionation studies have shown
that CEA isolated by the conventional
method is a mixture of glycoproteins
which differ significantly in their carbo-
hydrate composition and structure and
their specific activity. The fact that the
antigenic activity of CEA is not altered
upon extensive degradation of the carbo-
hydrate moiety (Hammarstrom et al.,
1975) appears to rule out the possibility
that exterior sugar chains significantly
affect the affinity of the molecule by
steric hindrance. It seems reasonable
however to postulate subtle differences in
the structure of the antigenic determinant
or variations in the amount of carbo-
hydrate-rich non-CEA glycoprotein to
account for the different activities of the
CEA fractions.
This study has also shown that
borate ions can be used effectively in the
Con A chroinatography to separate CEA
with low specific activity (fraction 2A)
which is weakly bound to the column,
from CEA with high specific activity.
Borate ions are known to complex with
vicinal--cis hydroxyl groups and they
probably compete with Concanavalin A
for these groups on non-reducing oc-D-
mannose residues present in fraction 2A
(Svensson, Hammarstrom and Kabat,
1970).
The use of Concanavalin A affinity
chromatography for the rapid isolation
of CEA with high potency (specific
activity 1.74, in Table I), directly from
dialysed perchloric acid extracts oftumour
tissue has eliminated the need for large
scale gel filtration and has enabled the
time and effort expended in the con-
TABLE III.-Carbohydrcate Analyses*
ofFraction 2B
Fucose
Mannose
Galactose
N-acetyl glucosamine
N-acetyl galactosaminle,
Sialic acid
Carbohydrate 00t
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FIn. 2. Concanavalin A affinity chromatography of perchloric acid extract of pooled serum from
11 patients with colonic caincer. The fractions were assayed for CEA in our routine assay (0 O
CEA,. . absorbaince at 280 nim).
ventional procedure to be substantially
reduced. The yield of CEA obtained
by this method appears to be significantly
lower than that reported for conventional
preparations even allowing for variations
in the CEA content of metastatic colonic
tumours. It is however of the same order
of magnitude as the CEA content of
similar tissue measured by radioimmuno-
assay (Khoo et al., 1973). In our ex-
perience we have found that the yield
of CEA prepared by the conventional
method and measured as freeze-dried
weight, depends to a large extent on the
resolution achieved in the Sepharose 4B
chromatography which is difficult to
optimize on a large scale.
Further studies, in which similar Con
A affinity chromatography teclhniquies
have been applied to a perchloric acid
extract of a pool of sera from patients
with colonic cancer, have demonstrated
that a fraction eluted with 2%0 methyl
glucoside contained nearly all of the CEA
activity (measured by radioimmunoassay)
with only minor proportions of CEA
being detected in the other fractions
(Fig. 2). This distribution is therefore
different from that found in tumouir
tissue extracts and suggests that the
immunologically active CEA component
in patients' serum may be very similar
if not identical to our CEA 2B of tumour
origin. Full details of this work and the
use of CEA 2B in radioimmunoassay will
be reported later.
CEA with high specific activity cannot
be isolated easily by separation methods
which depend on differences in molecular
charge, size and shape, nor even by
affinity chromatography using specific
anti-CEA antibodies. Our studies suggest
that in order to obtain CEA with high
specific activity it is convenient to adopt
the additional parameter of lectin binding
capacity. Before the significance of our
work can be fully evaluated in terms
of possible improvements in the clinical
application of CEA it is necessary to
know how the proportions of the CEA
fractions found in serum vary with
different diseases.
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